Market Access in Healthcare
For each market access process, you have to coordinate various departments in your organization with different decision-makers and external service providers while constantly making vital strategic decisions. Since the German AMNOG legislation came into effect in 2011, advisors in healthcare has successfully executed projects with a variety of objectives for several pharmaceutical manufacturers. advisors in healthcare also provides competent and efficient support in the market access of diagnostics or MedTech products.
Together with you, we develop promising strategies for product launch, dossier preparation or negotiations with decision-making bodies. While executing these workstreams, we always keep up an integrated approach to the management of important stakeholders. advisors in healthcare can act as an external Market Access department that provides tailored support though all phases of a product's lifecycle.
What we can do for you
We will present you with a viable pathway to achieve stakeholder support for your pharma, diagnostic or MedTech product. At the same time, the advisors in healthcare Market Access specialists lead the way though the regulatory thicket in order to work with you in devising a strategy for a successful market access for your product.
The high complexity of the Market Access processes with their multitude of parallel project streams and the necessity to coordinate internal and external collaborators can only be mastered by stringent project management. advisors in healthcare has proven the worth of its perfectly attuned project management processes leading to excellent results for our clients in several Market Access and AMNOG value dossier projects governed by German §35A SGB V.
advisors in healthcare supports its clients in all phases of their market access projects. If required, our experts may assume the role of an external market access department. They initiate, coordinate and monitor concrete projects and provide strategic input to facilitate project success. In addition, they provide active assistance for German Federal Joined Committee hearings (Gemeinsamer Bundesausschuss, G-BA) or negotiations with other decision-making bodies